Plain-English translation of NCT02671448 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether patients who need stem cell transplants can safely receive their care and recovery support at home instead of in a hospital. Researchers at Memorial Sloan Kettering Cancer Center want to see if home-based care after stem cell transplantation is safe, improves how patients feel about their treatment, and helps them recover better. Studies from other hospitals have shown this approach works well.
Currently, most patients who receive stem cell transplants must stay in the hospital for weeks during their recovery, which can be stressful and expensive. Earlier research suggests that recovering at home with proper medical support and a trained caregiver might be just as safe, reduce the risk of picking up infections, and make patients happier — so this trial aims to confirm whether this new approach works at Memorial Sloan Kettering.
If you're accepted into this trial, you would receive your stem cell transplant through the standard hospital process, but then return home to recover with your caregiver providing day-to-day support and the medical team monitoring you remotely. Your caregiver would complete training on how to help during your recovery, and you would share information through surveys, video diaries, and assessments with your care team. Once your blood counts recover (engraftment), you would transition back to regular clinic visits at Memorial Sloan Kettering.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States